First-ever Targeted Treatment for Cancer of Bile Ducts Approved by FDA
Recently, the U.S. Food and Drug Administration has granted approval to the use of Pemazyre (pemigatinib)to Incyte Corporation in the treatment of certain types of cancerous formations in the bile ducts of a person. More specifically, the drug was tested and seen to be effective for advanced stages of cholangiocarcinoma by scientists. Cholangiocarcinoma is a…